Regenerative medicine (RM) is one of the most promising fields of regenerative medicine, with regenerative ophthalmology (RO) being one of the most active domains. The ability of revolutionary therapies to treat a number of disorders, ranging from AMD to congenital degenerations, is being explored. Regenerative ophthalmology (RO) strives to restore function by employing biomaterials, cells, and bioactive substances to replace or regenerate tissues and organs. These unique therapeutic techniques have the potential to improve the effectiveness and efficiency of ocular disease management. With the advancement of tissue engineering tools, RO researchers have focused their attention on the regeneration of lost or injured eye tissues as a new way to cure visual impairment and blindness caused by ocular degenerative disorders, trauma, or infection.
Important Alert:
X
Title : Optic nerve orthograde axonal transport in abusive head trauma suspects
Minckler Don S, UCI, Gavin Herbert Eye Inst., United States
Title : Ultra-Widefield protocol enhances automated classification of diabetic retinopathy severity with OCT angiography
Kasra Rezaei, University of Washington, United States
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Various types of ocular injuries and highlights the significance of timely treatment to prevent visual loss
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Improving the quality of aftercare in patients received pars plana vitrectomy surgery
Hiu Kwan Fiona Fung, NHS Greater Glasgow and Clyde, United Kingdom
Title : Maintaining optimal oxygen saturation—the key to reduce both severe ROP & neurodisability
Hiranmoyee Das, Nazareth Hospital, India